Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimodality Therapy vs Surgery Alone for Esophageal Cancer
NCT00003118Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 1997
- Primary completion
- Mar 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin and fluorouracil in esophageal cancer (2 arms), sponsored by Cancer and Leukemia Group B. Primary endpoint: Overall Survival at 5 years. Started Oct 1997; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00003118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003118.